MDxHealth to Participate in 43rd Annual Cowen Healthcare Conference
February 28, 2023 16:30 ET
|
mdxhealth
NEWS RELEASEFEBRUARY 28, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 28, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH), a commercial-stage precision diagnostics...
MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
February 22, 2023 16:30 ET
|
mdxhealth
NEWS RELEASEFEBRUARY 22, 2023, 4:30pm ET/ 22:30 CET Company to Host Conference Call with Live Q&A, March 8, 2023 at 4:30pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 22, 2023...
Déclaration de Transparence d'un Actionnaire de MDxHealth
February 21, 2023 16:30 ET
|
mdxhealth
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE21 FÉVRIER 2023, 16h30 EDT/22h30 CET IRVINE, CA, et HERSTAL, BELGIQUE – le 21 FÉVRIER 2023 – MDxHealth SA (Nasdaq et Euronext Brussels: MDXH) (la...
MDxHealth Shareholder Transparency Declaration
February 21, 2023 16:30 ET
|
mdxhealth
NEWS RELEASE – REGULATED INFORMATIONFEBRUARY 21, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – 21 February 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the...
MDxHealth annonce une mise à jour des actions et des droits de vote en circulation et la mise à jour de son calendrier financier
February 15, 2023 16:30 ET
|
mdxhealth
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE15 FÉVRIER 2023, 16h30 EDT/22h30 CET IRVINE, CA, et HERSTAL, BELGIQUE – 15 février 2023 – MDxHealth SA (NASDAQ/Euronext : MDXH) (“mdxhealth” ou la...
MDxHealth Announces Update of Outstanding Shares and Voting Rights and Update of Financial Calendar
February 15, 2023 16:30 ET
|
mdxhealth
NEWS RELEASE – REGULATED INFORMATIONFEBRUARY 15, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 15, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH) (“mdxhealth” or the...
MDxHealth Announces UnitedHealthcare to Provide Commercial Coverage for the Genomic Prostate Score (GPS) Test
February 13, 2023 16:00 ET
|
mdxhealth
NEWS RELEASE 13 FEBRUARY 2023, 4:00PM ET / 22:00 CET UnitedHealthcare singles out mdxheath’s GPS test as its only commercially-covered test to risk stratify men newly diagnosed with localized...
MDxHealth annonce la détermination du prix de l'offre d'ADSs aux États-Unis
February 03, 2023 08:00 ET
|
mdxhealth
COMMUNIQUÉ DE PRESSE INFORMATION PRIVILÉGIÉE ET RÉGLEMENTÉE3 FÉVRIER 2023, 8h00 EDT/14h00 CET MDxHealth annonce la détermination du prix de l'offre d'ADSs aux États-Unis IRVINE, CA, et HERSTAL,...
MDxHealth Announces Pricing of Offering of ADSs in the United States
February 03, 2023 08:00 ET
|
mdxhealth
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONFEBRUARY 3, 2023, 8:00 am ET/ 14:00 CET MDxHealth Announces Pricing of Offering of ADSsin the United States IRVINE, CA, and HERSTAL, BELGIUM –...
MDxHealth Announces Launch of Offering of ADSs in the United States
February 01, 2023 16:00 ET
|
mdxhealth
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONFEBRUARY 1, 2023, 4PM ET/ 22:00 CET MDxHealth Announces Launch of Offering of ADSs in the United States IRVINE, CA, and HERSTAL,...